Scarica l'app Stockscreener
4.96
1.20%
-0.06
Dopo l'orario di chiusura:
4.71
-0.25
-5.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.02
Aprire:
$5.1
Volume 24 ore:
188.46K
Relative Volume:
1.67
Capitalizzazione di mercato:
$86.98M
Reddito:
-
Utile/perdita netta:
$-24.05M
Rapporto P/E:
-2.307
EPS:
-2.15
Flusso di cassa netto:
$-17.78M
1 W Prestazione:
-0.20%
1M Prestazione:
+17.54%
6M Prestazione:
+46.75%
1 anno Prestazione:
-9.82%
Intervallo 1D:
$4.651
$5.10
Intervallo di 1 settimana:
$4.651
$5.2184
Portata 52W:
$2.0278
$5.915
Envveno Medical Corporation Stock (NVNO) Company Profile
Nome
Envveno Medical Corporation
Settore
Industria
Telefono
949-261-2900
Indirizzo
70 DOPPLER, IRVINE
Confronta NVNO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
4.96 | 88.03M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Envveno Medical Corporation Borsa (NVNO) Ultime notizie
Is enVVeno Medical Corporation a good long term investmentExtraordinary performance - PrintWeekIndia
enVVeno Medical Corporation Stock Analysis and ForecastConsistently high yield - Autocar Professional
enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Lohud
What drives enVVeno Medical Corporation stock pricePhenomenal returns - jammulinksnews.com
What analysts say about enVVeno Medical Corporation stockExplosive wealth accumulation - Autocar Professional
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live - Corpus Christi Caller-Times
iTolerance, Inc. Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Bergen Record
Inside enVVeno Medical: CEO Shares Breakthrough Vision for Deep Venous Disease Treatment Revolution - Stock Titan
What makes enVVeno Medical Corporation stock price move sharplyPrecision Entry Strategy - Newser
JTC Team Announces Participating Line Up for the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Pocono Record
Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth - simplywall.st
How enVVeno Medical Corporation stock performs during market volatilityHigh Reward Risk Balanced Trading - Newser
Why enVVeno Medical Corporation stock attracts strong analyst attentionLow Risk Profit Ideas - Newser
Envoy Medical and enVVeno: Navigating Near-Term Turbulence for Long-Term Medical Device Dominance - AInvest
Jane Street Group LLC Acquires New Shares in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World
enVVeno Medical (NVNO) Shares Update on Promising Two-Year VenoV - GuruFocus
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting - The Oklahoman
enVVeno Medical (NVNO) Showcases Promising Two-Year Data for Ven - GuruFocus
enVVeno Medical (NVNO) Shares Update on Promising Two-Year VenoValve Trial Results | NVNO Stock News - GuruFocus
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pi - GuruFocus
enVVeno Medical announces two-year data from VenoValve pivotal study - TipRanks
enVVeno Medical announces interim two-year follow-up data on VenoValve trial - TipRanks
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting | NVNO Stock News - GuruFocus
VenoValve Shows 83% Success Rate in 2-Year Trial Data, FDA Decision Due 2025 | NVNO Stock News - Stock Titan
enVVeno Medical Corporation (NASDAQ:NVNO) Short Interest Up 19.4% in May - Defense World
NVNBWForm FWPFiling under Securities Act Rules 163/433 of free writing prospectuses - mx.advfn.com
Northern Trust Corp Raises Holdings in enVVeno Medical Corporation (NASDAQ:NVNO) - Defense World
Envveno Medical Corporation Azioni (NVNO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Envveno Medical Corporation Azioni (NVNO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gray Robert | Director |
Dec 31 '24 |
Buy |
2.94 |
3,500 |
10,290 |
11,155 |
| Shrivastava Sanjay | Director |
Dec 24 '24 |
Buy |
2.90 |
5,400 |
15,660 |
9,288 |
| Jenusaitis Matthew | Director |
Dec 19 '24 |
Buy |
2.53 |
9,620 |
24,339 |
16,545 |
| BERMAN ROBERT ANDREW | Chief Executive Officer |
Dec 19 '24 |
Buy |
2.55 |
12,000 |
30,600 |
222,236 |
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):